Current Assets: The sum of all assets that are classified as current, because they will provide a benefit within one year.
GT Biopharma, Inc. (GTBP) had Current Assets of $10.00M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-3.37M |
|
-- |
|
-- |
|
$2.85M |
|
$-2.85M |
|
$0.01M |
|
$-2.83M |
|
$-2.83M |
|
$-2.83M |
|
$-2.83M |
|
$-2.83M |
|
$-2.83M |
|
$-2.85M |
|
$-2.85M |
|
30.28M |
|
30.28M |
|
$-0.11 |
|
$-0.11 |
|
| Balance Sheet Financials | |
|
Current Assets |
$10.00M |
-- |
|
-- |
|
$10.00M |
|
$2.42M |
|
-- |
|
-- |
|
$2.42M |
|
$7.58M |
|
$7.58M |
|
$7.58M |
|
35.18M |
|
| Cash Flow Statement Financials | |
$-2.47M |
|
-- |
|
$4.58M |
|
$6.91M |
|
$9.02M |
|
$2.11M |
|
$0.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-37.38% |
|
-37.37% |
|
-28.34% |
|
-37.37% |
|
$0.22 |
|
$-0.08 |
|
$-0.08 |
|